{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T22:42:07Z","timestamp":1771022527444,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jocn-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jocn.2018.10.102","type":"journal-article","created":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T07:44:24Z","timestamp":1545551064000},"page":"160-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Intracerebral hemorrhage associated with warfarin versus non-vitamin K antagonist oral anticoagulants in Asian patients"],"prefix":"10.1016","volume":"61","author":[{"given":"Ho Geol","family":"Woo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inyoung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Seok","family":"Gwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baik Kyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beom Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Joon","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon-Ku","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2018.10.102_b0005","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/STROKEAHA.112.652065","article-title":"Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal","volume":"43","author":"Dowlatshahi","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2018.10.102_b0010","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.STR.26.8.1471","article-title":"Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses","volume":"26","author":"Hart","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2018.10.102_b0015","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2018.10.102_b0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1756285616659411","article-title":"Novel oral anticoagulants for the secondary prevention of cerebral ischemia: a network meta-analysis","volume":"9","author":"Katsanos","year":"2016","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.jocn.2018.10.102_b0025","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00415-014-7462-0","article-title":"Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis","volume":"262","author":"Caldeira","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2018.10.102_b0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/jnnp-2017-316631","article-title":"Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis","volume":"89","author":"Boulouis","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2018.10.102_b0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamaneurol.2015.3682","article-title":"Early clinical and radiological course, management, and outcome of intracerebral hemorrhage related to new oral anticoagulants","volume":"73","author":"Purrucker","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jocn.2018.10.102_b0040","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/ijs.12289","article-title":"Prescription frequency and predictors for the use of novel direct oral anticoagulants for secondary stroke prevention in the first year after their marketing in Europe\u2013a multicentric evaluation","volume":"9","author":"Luger","year":"2014","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jocn.2018.10.102_b0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jocn.2014.04.025","article-title":"Outcome following intracranial hemorrhage associated with novel oral anticoagulants","volume":"22","author":"Kasliwal","year":"2015","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2018.10.102_b0050","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1160\/TH13-11-0948","article-title":"Stroke prevention in atrial fibrillation: an Asian perspective","volume":"111","author":"Chiang","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jocn.2018.10.102_b0055","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4065\/mcp.2009.0278","article-title":"Warfarin sensitivity genotyping: a review of the literature and summary of patient experience","volume":"84","author":"Moyer","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jocn.2018.10.102_b0060","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.025","article-title":"Intracerebral hemorrhagic expansion occurs in patients using non-vitamin K antagonist oral anticoagulants comparable with patients using Warfarin","volume":"26","author":"Melmed","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jocn.2018.10.102_b0065","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.0000000000004362","article-title":"Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage","volume":"89","author":"Tsivgoulis","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2018.10.102_b0070","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1212\/WNL.0000000000003886","article-title":"Outcome of intracerebral hemorrhage associated with different oral anticoagulants","volume":"88","author":"Wilson","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2018.10.102_b0075","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.amjcard.2016.04.034","article-title":"Intracerebral hematoma occurring during warfarin versus non-vitamin K antagonist oral anticoagulant therapy","volume":"118","author":"Takahashi","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jocn.2018.10.102_b0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000462985","article-title":"Volume and characteristics of intracerebral hemorrhage with direct oral anticoagulants in comparison with Warfarin","volume":"7","author":"Adachi","year":"2017","journal-title":"Cerebrovasc Dis Extra"},{"key":"10.1016\/j.jocn.2018.10.102_b0085","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/STROKEAHA.114.006661","article-title":"Characteristics of intracerebral hemorrhage during rivaroxaban treatment: comparison with those during warfarin","volume":"45","author":"Hagii","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2018.10.102_b0090","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.2015.0846","article-title":"Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage","volume":"313","author":"Kuramatsu","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2018.10.102_b0095","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.STR.24.7.987","article-title":"Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality","volume":"24","author":"Broderick","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2018.10.102_b0100","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"46","author":"Hemphill","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2018.10.102_b0105","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijcard.2014.11.182","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal","volume":"180","author":"Lip","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jocn.2018.10.102_b0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","article-title":"Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis","volume":"9","author":"van Asch","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2018.10.102_b0115","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","article-title":"Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation","volume":"50","author":"Shen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jocn.2018.10.102_b0120","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2018.10.102_b0125","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2018.10.102_b0130","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2018.10.102_b0135","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2018.10.102_b0140","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/STROKEAHA.113.000990","article-title":"Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation","volume":"44","author":"Hori","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2018.10.102_b0145","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/STROKEAHA.113.002968","article-title":"Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial","volume":"45","author":"Wong","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2018.10.102_b0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ahj.2014.06.005","article-title":"Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial","volume":"168","author":"Goto","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jocn.2018.10.102_b0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5853\/jos.2014.16.2.73","article-title":"New oral anticoagulants may be particularly useful for asian stroke patients","volume":"16","author":"Bang","year":"2014","journal-title":"J Stroke"},{"key":"10.1016\/j.jocn.2018.10.102_b0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00701-016-3026-7","article-title":"Clinical and radiological course of intracerebral haemorrhage associated with the new non-vitamin K anticoagulants","volume":"159","author":"von der Brelie","year":"2017","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.jocn.2018.10.102_b0165","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1253\/circj.CJ-13-1534","article-title":"Intracranial hemorrhage during dabigatran treatment","volume":"78","author":"Komori","year":"2014","journal-title":"Circ J: official journal of the Japanese Circulation Society"},{"key":"10.1016\/j.jocn.2018.10.102_b0170","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1253\/circj.CJ-14-1209","article-title":"Intracranial hemorrhage caused by Non-Vitamin K Antagonist Oral Anticoagulants (NOACs)- multicenter retrospective cohort study in Japan","volume":"79","author":"Saji","year":"2015","journal-title":"Circ J: official journal of the Japanese Circulation Society"},{"key":"10.1016\/j.jocn.2018.10.102_b0175","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1161\/STROKEAHA.108.520668","article-title":"Hematoma growth in oral anticoagulant related intracerebral hemorrhage","volume":"39","author":"Cucchiara","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2018.10.102_b0180","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/01.WNL.0000138428.40673.83","article-title":"Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage","volume":"63","author":"Flibotte","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2018.10.102_b0185","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1179\/016164107X247227","article-title":"Warfarin-associated intraventricular hemorrhage","volume":"29","author":"Zubkov","year":"2007","journal-title":"Neurol Res"},{"key":"10.1016\/j.jocn.2018.10.102_b0190","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fneur.2018.00100","article-title":"Predicting prognosis of Intracerebral Hemorrhage (ICH): performance of ICH score is not improved by adding oral anticoagulant use","volume":"9","author":"Houben","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.jocn.2018.10.102_b0195","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1161\/01.STR.0000141933.75462.c2","article-title":"Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients","volume":"35","author":"Shireman","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2018.10.102_b0200","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jama.2017.21917","article-title":"Association of intracerebral hemorrhage among patients taking non-vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital mortality","volume":"319","author":"Inohara","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2018.10.102_b0205","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1067\/mcp.2003.26a","article-title":"Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients","volume":"73","author":"Takahashi","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jocn.2018.10.102_b0210","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa044503","article-title":"Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose","volume":"352","author":"Rieder","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2018.10.102_b0215","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1213\/ane.0b013e31819bceb1","article-title":"The role of tissue factor and factor VIIa in hemostasis","volume":"108","author":"Mackman","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jocn.2018.10.102_b0220","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/0091270006292127","article-title":"Safety, tolerability, pharmacodynamics, and pharmacokinetics of rivaroxaban\u2013an oral, direct factor Xa inhibitor\u2013are not affected by aspirin","volume":"46","author":"Kubitza","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jocn.2018.10.102_b0225","first-page":"2137","article-title":"Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: executive summary","volume":"38","author":"Heidbuchel","year":"2017","journal-title":"Eur Heart J"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586818315960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586818315960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T18:25:39Z","timestamp":1573583139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586818315960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":45,"alternative-id":["S0967586818315960"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2018.10.102","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracerebral hemorrhage associated with warfarin versus non-vitamin K antagonist oral anticoagulants in Asian patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2018.10.102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}